Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
NCT06233617Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing placebo, Dexamethasone and Dexmedetomidine (3 arms). Primary endpoint: Time to first need of opiate at 48 hours. Started Mar 2024; status: completed.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06233617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06233617.